9DQ3
Crystal structure of engineered Ipilimumab (mipi.4) Fab in complex with human CTLA-4
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 17-ID |
| Synchrotron site | APS |
| Beamline | 17-ID |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2022-10-05 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 1 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 84.023, 148.359, 48.439 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 41.960 - 1.640 |
| R-factor | 0.2336 |
| Rwork | 0.232 |
| R-free | 0.26800 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.007 |
| RMSD bond angle | 0.931 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.20.1_4487: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 74.180 | 1.765 |
| High resolution limit [Å] | 1.636 | 1.636 |
| Rmerge | 0.210 | 0.637 |
| Rmeas | 0.230 | 0.710 |
| Rpim | 0.093 | 0.308 |
| Total number of observations | 357216 | 14724 |
| Number of reflections | 59236 | 2964 |
| <I/σ(I)> | 5.1 | 1.6 |
| Completeness [%] | 78.3 | |
| Redundancy | 6 | 5 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 300 | 0.18 M calcium acetate hydrate, 22.5% w/v PEG3350 |






